SCHEMBL959150

SCHEMBL959150

Cc1ccc(Nc2cc(NC(=O)C3(C4(C(=O)Nc5cc(Nc6ccc7c(c6)CCC7)nc6ccccc56)CCCCC4)CCCCC3)c3ccccc3n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 7/20 0.43
RAB9A P51151 7/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 4/20 0.41
ALDH1A1 P00352 2/20 0.41
NFKB1 P19838 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
RXFP1 Q9HBX9 4/20 0.41
ALOX5 P09917 1/20 0.40
PPARG P37231 1/20 0.40
TP53 P04637 3/20 0.39
LMNA P02545 1/20 0.39
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL196311 0.86 MAPT (0.41) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL959149 0.85 RXFP1 (0.53) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL196682 0.81 IGF1R (0.49) MAPTSMN1; SMN2RXFP1TP53
SCHEMBL243470 0.78 RXFP1 (0.59) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL247393 0.77 RXFP1 (0.57) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL197114 0.76 MAPT (0.49) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL1976142 0.75 RXFP1 (0.53) KMT2ANPC1RAB9AMAPTRXFP1
SCHEMBL935627 0.74 RXFP1 (0.51) KMT2ANPC1RAB9AMAPTRXFP1
SCHEMBL196310 0.71 RXFP1 (0.47) KMT2ANPC1RAB9AMAPTRXFP1
SCHEMBL196063 0.67 RXFP1 (0.60) MEN1KMT2ANPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9668959-B2 A3 adenosine receptor ligands for modulation of pigmentation ORADIN PHARMACEUTICAL LTD. (IL) 2017-06-06 US disclosed
EP-2456419-B1 A3 ADENOSINE RECEPTOR LIGANDS FOR MODULATION OF PIGMENTATION ORADIN PHARMACEUTICAL LTD (IL) 2016-11-23 EP disclosed
US-20160136079-A1 A3 ADENOSINE RECEPTOR LIGANDS FOR MODULATION OF PIGMENTATION ORADIN PHARMACEUTICAL LTD. (IL) 2016-05-19 US disclosed
US-9199102-B2 A3 adenosine receptor ligands for modulation of pigmentation ORADIN PHARMACEUTICAL LTD. (IL) 2015-12-01 US disclosed
US-20120134945-A1 A3 ADENOSINE RECEPTOR LIGANDS FOR MODULATION OF PIGMENTATION ORADIN PHARMACEUTICAL LTD. (IL) 2012-05-31 US disclosed
EP-2456419-A1 A3 ADENOSINE RECEPTOR LIGANDS FOR MODULATION OF PIGMENTATION Oradin Pharmaceutical Ltd. (IL) 2012-05-30 EP disclosed
WO-2011010306-A1 A3 ADENOSINE RECEPTOR LIGANDS FOR MODULATION OF PIGMENTATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2011-01-27 WO disclosed